Patents by Inventor Haruo Nukaya

Haruo Nukaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8110601
    Abstract: A novel compound, a novel ?1 adrenergic receptor antagonistic agent, and a novel composition are provided which are capable of exerting a therapeutic effect on treatment of hypertension as well as treatment of prostatic hypertrophy and the like.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: February 7, 2012
    Assignee: Suntory Holdings Limited
    Inventors: Toshiyuki Wakimoto, Haruo Nukaya, Yoshihide Suwa, Yoshiaki Yokoo
  • Patent number: 7799763
    Abstract: A muscle-strengthening, anti-inflammatory, antiasthmatic, antidiarrheal or an antidepressant method, or a method for the treatment of diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, said method comprising: administering to skin a composition comprising (a) at least one member selected from the group consisting of isoflavones and isoflavone glycosides, (b) curcumin, and (c) cholic acid or at least one member selected from the group consisting of scymnol and scymnol esters.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: September 21, 2010
    Assignee: Daicho Kikaku Incorporated Company
    Inventors: Kenkichi Okada, Akio Ochiai, Masaki Kosuge, Takao Daicho, Kuniro Tsuji, Haruo Nukaya, Oto Miura
  • Publication number: 20100004328
    Abstract: A novel compound, a novel ?1 adrenergic receptor antagonistic agent, and a novel composition are provided which are capable of exerting a therapeutic effect on treatment of hypertension as well as treatment of prostatic hypertrophy and the like.
    Type: Application
    Filed: January 22, 2008
    Publication date: January 7, 2010
    Applicant: SUNTORY HOLDING LIMITED
    Inventors: Toshiyuki Wakimoto, Haruo Nukaya, Yoshihide Suwa, Yoshiaki Yokoo
  • Patent number: 7622450
    Abstract: The present invention relates to novel flavone C-glycoside derivatives or salts thereof, especially those showing an anti-allergic effect, and compositions containing them. Recently, cases of allergic diseases, especially pollenosis and atopic dermatitis have increased to such a degree that they have become a social problem. Flavones and their glycosides have been reported to have the effect of inhibiting histamine release from mast cells or an immunosuppressive effect and expected for application as allergy therapies. However, most flavones exhibit their effects only at high doses, so that effective compounds at lower doses are highly desired. The present invention provides novel components capable of treating allergic diseases at low doses and compositions containing them.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: November 24, 2009
    Assignee: Suntory Holdings Limited
    Inventors: Yoshiyuki Ishikura, Kuniro Tsuji, Haruo Nukaya
  • Publication number: 20080242855
    Abstract: It is intended to provide a process for efficiently producing a flavone C glycoside derivative represented by the formula (1) which is an antiallergic substance or its salt, or a flavone C glycoside derivative represented by the formula (4) or its salt. According to this process, the flavone C glycoside derivative represented by the formula (1) or its salt and the flavone C glycoside derivative represented by the formula (4) can be easily and efficiently synthesized by using isovitexine and vitexine contained in herbs and so on as the starting materials.
    Type: Application
    Filed: March 28, 2005
    Publication date: October 2, 2008
    Inventors: Kuniro Tsuji, Haruo Nukaya
  • Publication number: 20070129316
    Abstract: A muscle-strengthening, anti-inflammatory, antiasthmatic, antidiarrheal or an antidepressant method, or a method for the treatment of diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, said method comprising: administering to skin a composition comprising (a) at least one member selected from the group consisting of isoflavones and isoflavone glycosides, (b) curcumin, and (c) cholic acid or at least one member selected from the group consisting of scymnol and scymnol esters.
    Type: Application
    Filed: December 21, 2006
    Publication date: June 7, 2007
    Applicant: DAICHO KIKAKU INCORPORATED COMPANY
    Inventors: Kenkichi OKADA, Akio Ochiai, Masaki Kosuge, Takao Daicho, Kuniro Tsuji, Haruo Nukaya, Oto Miura
  • Publication number: 20050288237
    Abstract: The present invention relates to novel flavone C-glycoside derivatives or salts thereof, especially those showing an anti-allergic effect, and compositions containing them. Recently, cases of allergic diseases, especially pollenosis and atopic dermatitis have increased to such a degree that they have become a social problem. Flavones and their glycosides have been reported to have the effect of inhibiting histamine release from mast cells or an immunosuppressive effect and expected for application as allergy therapies. However, most flavones exhibit their effects only at high doses, so that effective compounds at lower doses are highly desired. The present invention provides novel components capable of treating allergic diseases at low doses and compositions containing them.
    Type: Application
    Filed: July 3, 2003
    Publication date: December 29, 2005
    Inventors: Yoshiyuki Ishikura, Kuniro Tsuji, Haruo Nukaya
  • Publication number: 20050208197
    Abstract: A substance capable of stimulating the movement of digestive tract, comprising a compound of the formula: (I) (active substance ? and active substance ? being stereoisomers), which substance is derived from natural products and hence cause no side effects, is highly safe even when continuously used for a prolonged period of time and can be widely employed as additives to refreshments, etc.; and a refreshment containing an additive comprising the stimulating substance. In particular, a digestive tract movement stimulating substance capable of acting on muscarine M3 receptor, obtained from beer through isolation and purification, which substance is one having drinkability stimulating effect; and a composition from natural products or natural processed products, comprising the above substance. The thus provided substance or composition is used as an additive to refreshment, thereby providing a refreshment capable of stimulating the movement of digestive tract.
    Type: Application
    Filed: June 26, 2003
    Publication date: September 22, 2005
    Inventors: Yoshihide Suwa, Wataru Fujii, Hisako Hori, Yoshiaki Yokoo, Haruo Nukaya, Kuniro Tsuji
  • Publication number: 20030203057
    Abstract: An object of the present invention is to provide a pharmaceutical agent or composition useful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, and a dermatological agent or composition suitable for skin applications, which can treat or prevent muscle weakening and inflammation, in particular arthritis, by its muscle-strengthening and/or anti-inflammatory actions, said agent or composition comprising isoflavone and/or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and/or scymnol and/or a scymnol ester.
    Type: Application
    Filed: December 12, 2002
    Publication date: October 30, 2003
    Applicant: DAICHO KIKAKU INCORPORATED COMPANY
    Inventors: Kenkichi Okada, Akio Ochiai, Masaki Kosuge, Takao Daicho, Kuniro Tsuji, Haruo Nukaya, Oto Miura
  • Patent number: 5122354
    Abstract: A crystallized, stable histidine-hydrogen peroxide adduct intermolecular-bonded at 1:1 ratio is provided.
    Type: Grant
    Filed: July 20, 1990
    Date of Patent: June 16, 1992
    Assignee: Tokai Denka Kogyo Kabushiki Kaisha
    Inventors: Kuniro Tsuji, Haruo Nukaya, Yasuhiro Kanaya